General Information of DTT (ID: TTVSMOH)

DTT Name Sphingosine-1-phosphate receptor 2 (S1PR2) DTT Info
Gene Name S1PR2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amiselimod DMI7CYZ Ulcerative colitis DD71 Phase 2 [1]
------------------------------------------------------------------------------------
6 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Jte 013 DMS3HNM Discovery agent N.A. Patented [2]
SCHEMBL15295829 DMK0T9E N. A. N. A. Patented [2]
Unii-R228S06soh DMUHSAZ N. A. N. A. Patented [2]
US8975409, Comparative compound B DM4S5DF N. A. N. A. Patented [3]
US8975409, Example 13 DMVB42P N. A. N. A. Patented [3]
US8975409, Example 9(3) DMJQOAE N. A. N. A. Patented [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Patented Agent(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AUY954 DMVGIO5 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk. Br J Pharmacol. 2017 Jan;174(1):15-27.
2 Sphingosine 1-phosphate receptor antagonists. US9663511.
3 Phenyl derivative. US8975409.
4 A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol. 2006 Nov;13(11):1227-34.